Organigram Global Inc. is focused on producing cannabis for adult recreational consumers. Organigram Global Inc., formerly known as OrganiGram Holdings Inc, is based in TORONTO.
| Revenue (Most Recent Fiscal Year) | $117.47M |
| Net Income (Most Recent Fiscal Year) | $-33.39M |
| PE Ratio (Current Year Earnings Estimate) | 82.80 |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 1.33 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 0.64 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | 8.17% |
| Net Margin (Trailing 12 Months) | 8.05% |
| Return on Equity (Trailing 12 Months) | -5.93% |
| Return on Assets (Trailing 12 Months) | -4.39% |
| Current Ratio (Most Recent Fiscal Quarter) | 3.42 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.90 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | 1.33 |
| Book Value per Share (Most Recent Fiscal Quarter) | $2.03 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.05 |
| Earnings per Share (Most Recent Fiscal Year) | $-0.25 |
| Diluted Earnings per Share (Trailing 12 Months) | $0.10 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Common Shares Outstanding | 133.88M |
| Free Float | 133.76M |
| Market Capitalization | $184.76M |
| Average Volume (Last 20 Days) | 0.57M |
| Beta (Past 60 Months) | 1.35 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 0.09% |
| Percentage Held By Institutions (Latest 13F Reports) | 34.63% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |